Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
Yaqiong Zhan(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Yunqing Qiu(Westlake University), Zhe Wu(Shanxi Agricultural University), Lushun Jiang(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Xuehang Jin(Jinhua Academy of Agricultural Sciences), Li Wang(Southwest Petroleum University), Wei Yu(University of Virginia), Li Zhang(Zhejiang University), Shuaibing Ying(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Jiepeng Tong(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Yan Lou(First Affiliated Hospital Zhejiang University)
Cited by 155
Related Papers
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
|Nucleic Acids Research|2021|710
TTD: <i>Therapeutic Target Database</i> describing target druggability information
|Nucleic Acids Research|2023|578
A super pan-genomic landscape of rice
|Cell Research|2022|381
Acoustic non-Hermitian skin effect from twisted winding topology
|Nature Communications|2021|335